Mark Morgan

3PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 25, 2023
Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer.

Stephanie L Wethington, Payal D Shah, Lainie Martin

|Sep 07, 2022
A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor-Positive Ovarian Cancer (Study 006).

Janos L Tanyi, Leslie M Randall, Setsuko K Chambers

|Jun 06, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

Bradley J Monk, Christine Parkinson, Myong Cheol Lim

Pageof 1

Frequent Collaborators

2 joint publications

Janos L Tanyi

1 joint publications

Bradley J Monk

1 joint publications

Myong Cheol Lim

1 joint publications

David M O'Malley